I am a pediatric oncologist who treats children with many different cancers, including leukemia, lymphoma, kidney tumors, and liver tumors. I am also involved in the care of patients who are receiving a stem cell transplant as part of their treatment. I am a member of the Children’s Oncology Group and participate in many of their clinical trials.
In my laboratory research, my colleagues and I are analyzing the molecular basis of sarcomas. We are using the latest technologies to see which genes or pathways in these tumors are turned on or off. We hope to identify new therapeutic targets and translate these findings into new treatments for children with sarcomas and, hopefully, other types of cancers.
I first came to Memorial Sloan Kettering as a medical student working with the Pediatric Stem Cell Transplant Team and found the patients and their families to be incredibly inspiring. Years later, I am proud to be a member of the attending staff and a part of the Department of Pediatrics at Memorial Sloan Kettering. We are a dedicated team of professionals that includes physicians, nurses, social workers, teachers, and child life specialists. We provide both medical and emotional services for children receiving treatment here to make this experience as comforting for them as possible.
- Clinical Expertise: Pediatric Leukemia and Lymphoma; Pediatric Tumors of the Kidney; Bone Marrow Transplantation
- Languages Spoken: English
- Education: MD, New York Medical College
- Residencies: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
- Fellowships: Memorial Sloan Kettering Cancer Center; NewYork-Presbyterian Hospital
- Board Certifications: Pediatrics; Pediatric Hematology/Oncology
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.
Clinical Trials Led by Rachel Kobos
Clinical Trials Co-Investigated by Rachel Kobos
- A Phase I Study of Immunotherapy with Genetically Modified T Cells Targeting CD19 in Pediatric and Young Adult Patients with Relapsed B-Cell Acute Lymphoblastic Leukemia
- A Phase I Study of MPDL3280A (Atezolizumab) Immunotherapy in Children and Young Adults with Persistent Solid Tumors
- A Phase II Study of 5'-Azacitidine to Prevent Recurrence in Patients Who Had a Donated Stem Cell Transplant for Acute Myeloid Leukemia or Myelodysplastic Syndromes
- A Phase III Study of Brentuximab Vedotin to Treat Newly Diagnosed Hodgkin Lymphoma in Children and Adolescents
- Treatment of Patients with Newly Diagnosed Standard Risk B-precursor Acute Lymphoblastic Leukemia
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more